Randomized trial of misoprostol in patients with chronic renal transplant rejection

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Hilbrands, L B ^a   Rischen Vos, J ^b   Hene R ^c   Weimar, W ^b   Assmann, K ^a   Hoitsma, A J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chronic rejection; Misoprostol; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MISOPROSTOL; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT FAILURE; HUMAN; HYPERMENORRHEA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0029910387     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01663.x     Document Type: Article

References (14)

1. Bia MJ (1995) Nonimmunologic causes of late renal graft loss. Kidney Int 47: 1470-1480
2. Curtis LD, Anwar N, Briggs JD, Buckels JA, Jones M, Karim MS, Koffman G, McGregor E, Neild G, Riad HN (1993) Misoprostol in renal transplantation. Transplant Proc 25: 602
3. Duffie GP, Romanelli RR, Ellis NK, Young MR, Wepsic HT (1988) The effects of E series prostaglandins on blastogenic responses in vitro and graft vs. host responses in vivo. Immunopharmacol Immunotoxicol 10: 597-615
4. Dunn J, Golden D, Van Buren CT, Lewis RM, Lawen J, Kahan BD (1990) Causes of graft loss beyond two years in the cyclosporine era. Transplantation 49: 349-353
5. Garris RE, Kirkwood CF (1989) Misoprostol: a prostaglandin E1 analogue. Clin Pharm 8: 627-644
6. Hosteller TH (1994) Chronic transplant rejection. Kidney Int 46: 266-279
7. Moran M, Mozes MF, Maddux MS, Veremis S, Bartkus C, Ketel B, Pollak R, Wallemark C, Jonasson O (1990) Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and pred-nisone. N Engl J Med 322: 1183-1188
8. Palier MS (1988) Effects of the prostaglandin E1 analog misoprostol on cyclosporine nephrotoxicity. Transplantation 45: 1126-1131
9. Palier MS, Manivel JC (1992) Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int 42: 1345-1354
10. Pouteil Noble C, Chapuis F, Berra N, Hadj Aissa A, Lacavalerie B, Lefrancois N, Martin X, Touraine JL (1994) Misoprostol in renal transplant recipients: a prospective, randomized, controlled study on the prevention of acute rejection episodes and cyclosporin A nephrotoxicity. Nephrol Dial Transplant 9: 552-555
11. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DE, Najarian JS (1991) Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 214: 679-688
12. Tullius SG, Tilney NL (1995) Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59: 313-318
13. Wiederkehr JC, Dumble L, Pollak R, Moran M (1990) Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue. Aust N Z J Surg 60: 121-124
14. Wilkie ME, Beer JC, Newman D, Raftery MJ, Marsh FP (1992) Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporine-treated renal allograft recipients. Transplantation 54: 565-567